2020-04-22T10:40:24Z
2020-04-22T10:40:24Z
2019-11-10
2020-04-22T10:40:24Z
The role of gut microbiota in human health has been investigated extensively in recent years. The association of dysbiosis, detrimental changes in the colonic population, with several health conditions has led to the development of pro-, pre- and symbiotic foods. If not absorbed in the small intestine or secreted in bile, polyphenols and other food components can reach the large intestine where they are susceptible to modification by the microbial population, resulting in molecules with potentially beneficial health effects. This review provides an overview of studies that have detected and/or quantified microbial phenolic metabolites using high-performance liquid chromatography as the separation technique, followed by detection through mass spectrometry. Both in vitro experimental studies and human clinical trials are covered. Although many of the microbial phenolic metabolites (MPM) reported in in vitro studies were identified in human samples, further research is needed to associate them with clinical health outcomes.
Article
Versió publicada
Anglès
Microbiota intestinal; Salut; Polifenols; Espectrometria de masses; Cromatografia de líquids d'alta resolució; Gastrointestinal microbiome; Health; Polyphenols; Mass spectrometry; High performance liquid chromatography
MDPI
Reproducció del document publicat a: https://doi.org/10.3390/nu11112725
Nutrients, 2019, vol. 11, num. 11, p. 2725
https://doi.org/10.3390/nu11112725
cc-by (c) Marhuenda-Muñoz, María et al., 2019
http://creativecommons.org/licenses/by/3.0/es